Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables

Verify with FDA CVM →

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
5
Deaths Reported
3330.0%
Death Rate

Active Ingredients

Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables

Administration Routes

Oral

Species Affected

Dog 15

Most Affected Breeds

Retriever - Labrador 6
Doberman Pinscher 2
Retriever - Golden 2
Mixed (Dog) 1
Mastiff 1
Terrier - Jack Russell 1
Beagle 1
Spaniel - Cocker American 1

Most Reported Reactions

Other abnormal test result NOS 9
Diarrhoea 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Intestinal perforation 4
Tachypnoea 3
Abdominal discomfort 3
Vomiting 2
Death 2
Tachycardia 2
Peritonitis 2
Emesis 2
Death by euthanasia 2

Outcome Breakdown

Euthanized
4 (26.7%)
Recovered/Normal
4 (26.7%)
Outcome Unknown
3 (20.0%)
Ongoing
2 (13.3%)
Died
1 (6.7%)
Recovered with Sequela
1 (6.7%)

Data Summary

Metric Value
Total adverse event reports 15
Reports involving death 5
Case-fatality rate (reported events) 3330.0%
Distinct species in reports 1
Distinct breeds in reports 8
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 15 adverse event reports referencing Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables, including 5 reports in which the animal died — a 3330.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables. Reported administration route is Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables reports are Dog (15 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (6), Doberman Pinscher (2), Retriever - Golden (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables are Other abnormal test result NOS (9), Diarrhoea (4), Lethargy (see also Central nervous system depression in 'Neurological') (4), Intestinal perforation (4). Of the 15 reports with a coded outcome, Euthanized is the leading category at 26.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Glucosamine/ Chondroitin Sulfate Plus Avocado/Soybean Unsaponifiables.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial